Suppression of anti-drug antibodies to infliximab or adalimumab with the addition of an immunomodulator in patients with inflammatory bowel disease.
Saved in:
| Title: | Suppression of anti-drug antibodies to infliximab or adalimumab with the addition of an immunomodulator in patients with inflammatory bowel disease. |
|---|---|
| Authors: | Strik, A. S.1, Brink, G. R.1, Ponsioen, C.1, Mathot, R.2, Löwenberg, M.1, D'Haens, G. R.1 g.dhaens@amc.uva.nl |
| Source: | Alimentary Pharmacology & Therapeutics. Apr2017, Vol. 45 Issue 8, p1128-1134. 7p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
